Schweizer J - Search Results

1

Candesartan treatment for peripheral occlusive arterial disease after stent angioplasty : a randomised, placebo-controlled trial.

Schindler C, Schweizer J, Müller A, Koch R, Hellner G, Fuchs W, Kirch W. Schindler C, et al. Among authors: schweizer j. Clin Drug Investig. 2005;25(2):89-97. doi: 10.2165/00044011-200525020-00001. Clin Drug Investig. 2005. PMID: 17523758

2

Use of abciximab and tirofiban in patients with peripheral arterial occlusive disease and arterial thrombosis.

Schweizer J, Kirch W, Koch R, Müller A, Hellner G, Forkmann L. Schweizer J, et al. Angiology. 2003 Mar-Apr;54(2):155-61. doi: 10.1177/000331970305400203. Angiology. 2003. PMID: 12678189 Clinical Trial.

3

Comparison of selective AT1-receptor blockade versus ACE inhibition for restenosis prophylaxis in patients with peripheral occlusive arterial disease after stent angioplasty: a randomized, controlled, proof-of-concept study.

Schindler C, Mueller A, Bramlage P, Boecking W, Kirch W, Schweizer J. Schindler C, et al. Among authors: schweizer j. Angiology. 2007 Dec-2008 Jan;58(6):710-6. doi: 10.1177/0003319707305962. Epub 2007 Oct 10. Angiology. 2007. PMID: 17928625 Clinical Trial.

4

Short- and long-term results of abciximab versus aspirin in conjunction with thrombolysis for patients with peripheral occlusive arterial disease and arterial thrombosis.

Schweizer J, Kirch W, Koch R, Müller A, Hellner G, Forkmann L. Schweizer J, et al. Angiology. 2000 Nov;51(11):913-23. doi: 10.1177/000331970005101104. Angiology. 2000. PMID: 11103860 Clinical Trial.

5

Comparison of angiotensin II receptor antagonists.

Kirch W, Horn B, Schweizer J. Kirch W, et al. Among authors: schweizer j. Eur J Clin Invest. 2001 Aug;31(8):698-706. doi: 10.1046/j.1365-2362.2001.00871.x. Eur J Clin Invest. 2001. PMID: 11473571 Review.

6

Effect of high dose verapamil on restenosis after peripheral angioplasty.

Schweizer J, Kirch W, Koch R, Hellner G, Uhlmann K. Schweizer J, et al. J Am Coll Cardiol. 1998 May;31(6):1299-305. doi: 10.1016/s0735-1097(98)00100-4. J Am Coll Cardiol. 1998. PMID: 9581724 Free article. Clinical Trial.

7

Short- and long-term results after thrombolytic treatment of deep venous thrombosis.

Schweizer J, Kirch W, Koch R, Elix H, Hellner G, Forkmann L, Graf A. Schweizer J, et al. J Am Coll Cardiol. 2000 Oct;36(4):1336-43. doi: 10.1016/s0735-1097(00)00863-9. J Am Coll Cardiol. 2000. PMID: 11028492 Free article. Clinical Trial.

8

Potential use of a low-molecular-weight heparin to prevent restenosis in patients with extensive wall damage following peripheral angioplasty.

Schweizer J, Müller A, Forkmann L, Hellner G, Kirch W. Schweizer J, et al. Angiology. 2001 Oct;52(10):659-69. doi: 10.1177/000331970105201002. Angiology. 2001. PMID: 11666130 Clinical Trial.

9

Comparative results of thrombolysis treatment with rt-PA and urokinase: a pilot study.

Schweizer J, Elix H, Altmann E, Hellner G, Forkmann L. Schweizer J, et al. Vasa. 1998 Aug;27(3):167-71. Vasa. 1998. PMID: 9747153 Clinical Trial.

10

[Current status of antihypertensive drug treatment in primary care practice at launch of the new renin inhibitor aliskiren (RASANT)].

Müller A, Schweizer J, Kirch W, Schindler C; RASANT-Studiengruppe. Müller A, et al. Among authors: schweizer j. Med Klin (Munich). 2010 Mar;105(3):155-62. doi: 10.1007/s00063-010-1025-7. Epub 2010 Mar 28. Med Klin (Munich). 2010. PMID: 20349293 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

305 results

Search Page